Park Cheol-Young相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial

在2型糖尿病患者中，洛贝格列酮作为恩格列净联合二甲双胍治疗的附加疗法可改善血糖控制：一项双盲、随机、安慰剂对照试验

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.70257

Seo, Da Hea; Min, Kyung Wan; Sohn, Ho Sang; Kim, Sang Yong; Jeong, In-Kyung; Park, Cheol-Young; Yoon, Kun-Ho; Kim, So Hun; Cha, Bong-Soo

发表日期：2026

文献求助收藏

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)

在韩国 2 型糖尿病合并血脂异常患者中，换用依折麦布 10 mg/瑞舒伐他汀 2.5 mg 的疗效和安全性：一项多中心前瞻性研究（EROICA 研究）

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.70258

Hong, Sangmo; Kim, Won J; Kim, Sungrae; Park, Jung H; Kang, Eun S; Moon, Min K; Kim, Jae T; Mok, Ji-Oh; Lee, Ki Y; Park, Cheol-Young; Lee, Chang B

发表日期：2026

文献求助收藏

Hepatorenal vulnerability flagged by glomerular hyperfiltration in metabolic liver disease: a large health-screening cohort evidence

代谢性肝病中肾小球高滤过提示肝肾脆弱性：一项大型健康筛查队列研究的证据

期刊:Diabetology & Metabolic Syndrome

影响因子:3.9

doi:10.1186/s13098-025-02070-3

Koo, Dae-Jeong; Kim, Yun Tae; Moon, Sun-Joon; Kwon, Hyemi; Park, Se Eun; Lee, Sang Min; Park, Cheol-Young; Lee, Won-Young; Cho, Sung Rae; Rhee, Eun-Jung

发表日期：2026

文献求助收藏

Differences Between Glycated Hemoglobin and Glucose Management Indicator in Real-Time and Intermittent Scanning Continuous Glucose Monitoring in Adults With Type 1 Diabetes

1型糖尿病成人患者实时和间歇扫描连续血糖监测中糖化血红蛋白与血糖管理指标的差异

期刊:Journal of diabetes science and technology

影响因子:3.7

doi:10.1177/19322968241262106

Yoo, Jee Hee; Moon, Sun Joon; Park, Cheol-Young; Kim, Jae Hyeon

发表日期：2026

文献求助收藏

Lower glycemic status was associated with pancreatic cancer risk in prediabetes, but not in diabetes: A nationwide cohort study

一项全国性队列研究表明，血糖水平较低与糖尿病前期患者的胰腺癌风险相关，但与糖尿病患者的胰腺癌风险无关。

期刊:Journal of Diabetes Investigation

doi:10.1111/jdi.70205

Koo, Dong-Hoe; Jung, Jin-Hyung; Han, Kyungdo; Park, Cheol-Young

发表日期：2026

文献求助收藏

Design Strategies Based on Electronic Interactions for Effective Catalysts in Lithium-Sulfur Batteries

基于电子相互作用的锂硫电池高效催化剂设计策略

期刊:Angewandte Chemie-International Edition

影响因子:16.9

doi:10.1002/anie.202425037

Son, Donghyeok; Park, Cheol-Young; Kim, Jinuk; Lim, Won-Gwang; Kim, Seoa; Lee, Jinwoo

发表日期：2025

文献求助收藏

Protective catalytic layer powering activity and stability of electrocatalyst for high-energy lithium-sulfur pouch cell

保护性催化层赋予高能量锂硫软包电池电催化剂活性和稳定性

期刊:Nature Communications

影响因子:15.7

doi:10.1038/s41467-025-56606-2

Kim, Seoa; Lim, Won-Gwang; Jung, Hyeonjung; Jeong, Yo Chan; Park, Cheol-Young; Yang, Seung Bo; Lee, Chang Hoon; Wang, Donghai; Sohn, Kwonnam; Han, Jeong Woo; Lee, Jinwoo

发表日期：2025

文献求助收藏

Use of an insulin titration protocol based on continuous glucose monitoring in postoperative cardiac surgery patients with type 2 diabetes and prediabetes: a randomized controlled trial

在2型糖尿病和糖尿病前期患者术后心脏手术中应用基于持续血糖监测的胰岛素滴定方案：一项随机对照试验

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-025-02747-z

Moon, Sun-Joon; Kim, Min-Su; Kim, Yun Tae; Lee, Ha-Eun; Lee, Young-Woo; Lee, Su-Ji; Chung, Euy-Suk; Park, Cheol-Young

免疫/内分泌

发表日期：2025

文献求助收藏

Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study

RAS抑制剂和SGLT2抑制剂单独或联合应用对合并糖尿病和高血压患者终末期肾病和/或全因死亡的影响：一项全国性队列研究

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-025-02846-x

Hong, Sangmo; Han, Kyungdo; Kim, Kyung-Soo; Park, Cheol-Young

发表日期：2025

文献求助收藏

Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality

暂时性MASLD与2型糖尿病、心血管疾病和死亡率的关联

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-025-02824-3

Han, Eugene; Han, Kyung-Do; Lee, Yong-Ho; Kim, Kyung-Soo; Hong, Sangmo; Park, Jung Hwan; Park, Cheol-Young

心血管疾病

发表日期：2025

文献求助收藏